Publication | Closed Access

Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs

Metabolic SyndromeNetwork PharmacologyHepatologyLiver PhysiologyDiabetesPharmacologyType 2PathologyMolecular MechanismHepatotoxicityLiver DiseaseFatty Liver DiseaseMetabolomicsMedicineDrug-induced Liver InjuryHealth Sciences